Protein kinase inhibition differentially regulates organic cation transport

Alexander M Gerlyand1, Daniel S Sitar

  • 1Department of Pharmacology and Therapeutics, University of Manitoba, A220-753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada.

Insights

This study reveals distinct regulation of organic cation transporters in kidney cells. Amantadine and tetraethylammonium (TEA) transport are differentially controlled by glucose levels, bicarbonate, and cAMP, impacting kidney function in diabetes.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Physiology

Background:

  • Diabetic rats exhibit altered amantadine and tetraethylammonium (TEA) transport in kidney tissue, with changes reversed by insulin.
  • This suggests differential regulation of organic cation transporters, necessitating further investigation into the underlying mechanisms.

Purpose of the Study:

  • To investigate the differential regulation of organic cation transporters in kidney cells.
  • To elucidate the roles of glucose, bicarbonate, and cyclic AMP (cAMP) in modulating transporter activity.

Main Methods:

  • Utilized native human embryonic kidney (HEK293) cells and rat organic cation transporter (rOCT)-transfected cells.
  • Manipulated glucose levels, bicarbonate presence, and employed cAMP analogues to assess transporter responses.

Main Results:

  • Short-term glucose starvation differentially affected amantadine and TEA transport, with bicarbonate modulating amantadine transport specifically.
  • cAMP analogues inhibited TEA transport while stimulating amantadine transport, with additive effects to insulin and bicarbonate influence.
  • Regulation of rOCT 1 and 2 was linked to transmembrane adenylyl cyclase, while amantadine transport involved soluble adenylyl cyclase.

Conclusions:

  • Intracellular cAMP microdomains play a crucial role in determining organic cation transport.
  • Soluble adenylyl cyclase, modulated by bicarbonate and lactate, influences amantadine transport, reconciling previous findings on transport affinity.
  • Findings support differential regulation of organic cation transporters, offering insights into kidney function in diabetes.

Related Concept Videos

Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...